What is the daily dose of Cabozantinib 20mg?

Cabozantinib is a targeted tyrosine kinase inhibitor commonly used to treat a variety of advanced malignant tumors and has a wide range of indications. The dosage selection has its own characteristics due to different indications, different dosage forms, and individual patient differences. Especially the daily dosage needs to be strictly implemented in accordance with the doctor's prescription and clinical guidelines. Common dosage forms of cabozantinib include tablets and capsules, of which the 20 mg dosage form is mainly used in capsule-form drug combinations. It is usually not the only dosage in the treatment plan, but is matched according to the overall recommended dosage.

In the treatment of metastatic medullary thyroid cancer (MTC), it is recommended to use cabozantinib capsules 140 mg once daily. This dose can be composed of taking several 20 mg capsules. For example, a patient may take seven 20 mg capsules daily to achieve a therapeutic dose of 140 mg. Medication should be taken 1 hour before or 2 hours after meals to ensure optimal drug absorption efficiency. It should be noted that capsule dosage forms and tablets cannot be used interchangeably because there are significant differences in the pharmacokinetic parameters of the two dosage forms in vivo.

When cabozantinib is used for renal cancer (RCC) and hepatocellular carcinoma (HCC), it is often used in tablet form, and the recommended dose is 60 mg orally once daily. If patients are receiving concomitant treatment with nivolumab, the cabozantinib dose will be adjusted to a 40 mg tablet once daily. In this type of treatment, doctors may adjust the dose to 20 mg tablets for daily use based on the patient's specific adverse reactions and tolerance. Therefore, in specific clinical situations, the 20 mg tablet may also become an option for dose adjustment, especially in the treatment of patients with greater toxicity or hepatic and renal dysfunction.

For the treatment of differentiated thyroid cancer (DTC), the recommended dose of cabozantinib is a 60 mg tablet once daily. However, during the actual treatment process, doctors will also choose a low-dose regimen to reduce the occurrence of adverse reactions based on clinical parameters such as patient weight, body surface area (BSA), and tolerance. At this time, the 20 mg dosage form may be in the form of tablets or capsules and used as part of a flexible combination to achieve personalized and precise treatment.

Reference:https://en.wikipedia.org/wiki/Cabozantinib